News

Robert Reddig, MD, neurologist at Saint Luke's Marion Bloch Neuroscience Institute, joined FOX 4's Afternoon Drive to break down what you need to know about migraines.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.

USA Today talked to Dr. Paul Chan about disparities found when analyzing the effectiveness of bystander CPR for cardiac arrest.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.

Dr. Sanjaya Gupta, electrophysiologist at Saint Luke's Mid America Heart Institute, talks with KCTV about risk factors and new treatment available at Saint Luke's Atrial Fibrillation Clinic.

During the COVID-19 pandemic, many are experiencing worsening or more frequent migraines. KCTV talked to a neurologist about what's causing this trend and what people can do to reduce migraines.

Amid the COVID-19 pandemic, neurologists are seeing many patients with worsening or more frequent migraines. KSHB talked to a neurologist about what's causing this trend.